Best Peptide for Tendon Repair Research
BPC-157 is the established leader for tendon and ligament repair research. Its growth hormone receptor upregulation, collagen type I synthesis promotion, and superior stability make it the go-to peptide for Achilles, rotator cuff, and patellar tendon studies.
TOP RECOMMENDATION
BPC-157 — Body Protection Compound-157
BPC-157 dominates tendon repair research through a mechanism specifically tuned to musculoskeletal extracellular matrix. Published ex-vivo Achilles tendon studies show BPC-157 significantly outperforms vehicle controls in tensile strength recovery, collagen fiber alignment, and fibroblast density at the repair site. Its 15-amino-acid sequence directly upregulates the growth hormone receptor in tendon fibroblasts — a pathway not replicated by TB-500's actin-sequestration mechanism. While TB-500 offers superior cell migration and systemic anti-inflammatory signaling, BPC-157's localized growth factor cascade is the precise biological tool for tendon-specific research.
WHY IT WINS
- Directly upregulates growth hormone receptor expression in tendon fibroblasts, accelerating extracellular matrix remodeling
- Promotes type I collagen synthesis specifically in tendon and ligament explants, demonstrated in Achilles transection models
- Smaller 15-amino-acid structure enables rapid tissue diffusion without complex folding or receptor gating requirements
- Superior reconstituted stability (30 days refrigerated) compared to larger peptides, reducing batch waste in multi-week studies
- Lower cost per milligram and simpler synthesis translates to more replicates per research budget
APPLICATION SUITABILITY MATRIX
| RESEARCH APPLICATION | BPC-157 | TB-500 |
|---|---|---|
| Tendon Fibroblast Proliferation | ||
| Collagen Type I Synthesis | ||
| Tendon-to-Bone Integration | ||
| Cell Migration at Wound Edge | ||
| Anti-Inflammatory Cytokine Modulation | ||
| Angiogenesis at Repair Site | ||
| Stability in Long-Term Studies | ||
| Cost per Replicate |
IDEAL RESEARCH APPLICATIONS
- Achilles tendon transection and repair models
- Rotator cuff tendon-to-bone healing studies
- Patellar ligament stress and recovery assays
- Medial collateral ligament (MCL) injury models
- Tendon fibroblast proliferation and collagen alignment readouts
ALTERNATIVE: TB-500
RUNNER-UP
TB-500 — Thymosin Beta-4 Fragment (17-23)
Consider when:
- Superior actin cytoskeleton regulation benefits studies examining tendon cell migration and adhesion dynamics
- Broader anti-inflammatory cytokine downregulation (TNF-α, IL-6) useful for chronic tendinopathy models
- Consider in combination with BPC-157 for advanced studies targeting both local collagen deposition and systemic inflammatory resolution
ANALYTICAL SPECIFICATIONS
Compound
Body Protection Compound-157
CAS Number
137525-51-0
Purity (HPLC)
≥ 99.2%
Molecular Weight
1,419.5 g/mol
Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Verification
HPLC + MS per batch
FREQUENTLY ASKED QUESTIONS
Why is BPC-157 better than TB-500 for tendon repair research?
BPC-157 directly upregulates the growth hormone receptor and promotes type I collagen synthesis in tendon fibroblasts — mechanisms central to tendon matrix remodeling. TB-500 regulates actin cytoskeleton dynamics and cell migration, which is more relevant to wound healing and systemic regeneration than localized tendon collagen deposition.
What concentration of BPC-157 should I use for tendon cell culture?
For tendon fibroblast cultures, BPC-157 is typically evaluated at 1–10 mcg/ml in complete media, with collagen synthesis readouts (hydroxyproline assay, Sirius Red staining) assessed at 48–72 hours. Include a vehicle control with bacteriostatic water alone.
Can I combine BPC-157 and TB-500 in a tendon repair study?
Yes. Many researchers use BPC-157 for localized collagen synthesis and TB-500 for cell migration and inflammatory modulation. Reconstitute each peptide separately and combine only at the point of application to your tissue model or cell culture.
How stable is BPC-157 for a 6-week tendon healing study?
Lyophilized BPC-157 is stable for ≥ 24 months at -20°C. Reconstituted BPC-157 remains stable for 30 days at 2–8°C. For multi-week studies, aliquot reconstituted solution into single-use vials and freeze at -20°C. Thaw each aliquot once and discard unused portion.
Is BPC-157 effective in bone-tendon insertion models?
Yes. Published research indicates BPC-157 accelerates tendon-to-bone healing in rotator cuff and ACL insertion models by enhancing fibrocartilage zone formation and collagen fiber organization at the enthesis.
REFERENCES
- [1]Chang, C.H. et al. (2011). Pentadecapeptide BPC 157 enhances the growth hormone receptor. Journal of Physiology-Paris, 105(2–3), 120–131.
- [2]Sikiric, P. et al. (2016). The pharmacological properties of the peptide BPC 157. Current Pharmaceutical Design, 22(32), 4966–4973.
- [3]Stupnisek, M. et al. (2015). BPC 157 as a prototype cytoprotective mediator. Journal of Physiology-Paris, 109(1–3), 119–129.
- [4]Seiwerth, S. et al. (2014). BPC 157 effect on healing. World Journal of Gastroenterology, 20(27), 8997–9005.
TOP RECOMMENDATION
BPC-157
Body Protection Compound-157
QUICK LINKS
RELATED RESEARCH GOALS
RESEARCH USE ONLY. All compounds are strictly for in-vitro laboratory research by qualified professionals. Not for human consumption, veterinary use, or clinical application.